Wednesday, August 24, 2011

ORID Process - Interpretive

Context:  At the 7/21 meeting, participants discussed emerging and ongoing major initiatives that involve our prevention, planning and partnership efforts with local health agencies.  Let's pause now and reflect on how we can take this information forward to be more effective in this interface.  To listen to an audio of that meeting go to  To view other supporting documents for that meeting, we've posted them online at  The purpose of this group collaboration post and comments is to get your thoughts on the following:

Interpretive:  So what?
1) What are we going to have to do to change the way we currently operate?
2) What new roles and ways of operating are we going to have to implement?
3) What are the most salient opportunities for collaboration?

How to provide your input:  To contribute your thoughts on our "Interpretive" effort, just click on "comments" at the bottom right of this post.  Enter your name, division/office or program and then your responses to the 3 questions.


  1. Tara Trujillo, Healthy Communities
    1. Understand each other's work and coordinate our programs. We have to build a customized approach to each community we work with.
    2. Less program-specific, more community-centric.
    3. Public health improvement plan, upcoming grants, new partnerships.

  2. Sallie Thoreson, Injury, Suicide and Violence Prevention Unit, PSD
    OPP needs to determine a way to keep PSD, and other divisions, informed about their work with LHDs.

    LHDs are asking that CDPHE have coordinated approach to oversight, deliverables, fiscal reporting for grants provided. CDPHE-all programs that fund LHDs need to try and streamline and coordinate our interactions with the locals.

  3. Sara Rodriguez
    1. Better balance the role of partner vs contractor or subrecipient of $$ with LHDs. Better communication coming out of OPP.
    2. STreamlined contracting process with ALL LHD funding from the State. Closer to a negotiated agreement than a contract?
    3. Consolidated chronic disease funding.